Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(9%)
Results Posted
29%(2 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_3
5
45%
Ph phase_1
5
45%
Ph phase_2
1
9%

Phase Distribution

5

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
5(45.5%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
5(45.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)

Detailed Status

Completed7
Terminated2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
77.8%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (45.5%)
Phase 21 (9.1%)
Phase 35 (45.5%)

Trials by Status

completed764%
recruiting19%
terminated218%
not_yet_recruiting19%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials
NCT07573176Phase 3

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Not Yet Recruiting
NCT06559306Phase 3

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Recruiting
NCT04513912Phase 3

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Completed
NCT04532749Phase 3

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Terminated
NCT03494907Phase 1

A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants

Completed
NCT05236868Phase 1

A Study of JNJ-42847922 (Seltorexant) in Healthy Participants

Completed
NCT05307692Phase 2

A Study of Seltorexant in Participants With Probable Alzheimer's Disease

Completed
NCT04533529Phase 3

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Completed
NCT04951609Phase 1

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

Terminated
NCT05106153Phase 1

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Completed
NCT04553042Phase 1

A Study of Seltorexant in Healthy Participants

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11